Skip to main content
IMVT logo
IMVT
(NASDAQ)
Immunovant, Inc.
$26.29-- (--)
Loading... - Market loading

Immunovant (IMVT) Stock Price & Financial Analysis

Immunovant Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.06 - $27.62
52-Week High$30.16
52-Week Low$13.52
Open$27.52
Volume1.28M
Average Volume (3M)1.52M
Market Cap4.99B
Shares Outstanding181.51M
Price to Book (P/B)5.06
EV/EBITDA-8.21
50-Day MA$26.28
200-Day MA$22.58
52-Week Change99.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immunovant

What is the current stock price for IMVT?

As of the latest trading session, IMVT stock trades at $26.53. The 52-week range is $13.52–$30.16, with a day range of $26.06–$27.62.

What is the P/E ratio for IMVT?

The P/E ratio (Price-to-Earnings) for IMVT is shown in the Key Statistics section. This valuation metric helps compare Immunovant, Inc. to industry peers.

Does IMVT pay dividends?

Immunovant does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMVT?

Based on 1 analyst, the consensus for IMVT is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMVT?

Immunovant's market capitalization is $4.82B, classifying it as a mid-cap company. Immunovant operates in the Healthcare sector within the Biotechnology industry.